Ogino H, Iwamatsu K, Katano K, Nakabayashi S, Yoshida T, Tsuruoka T, Inouye S, Kondo S
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd., Yokohama, Japan.
J Antibiot (Tokyo). 1990 Feb;43(2):174-88. doi: 10.7164/antibiotics.43.174.
A series of new aminothiazolylglycylcephalosporins with a mono- or dihydroxypyridonecarbonyl group at the alpha-amino group of the C-7 substituent have been prepared and antibacterial activity of these compounds was investigated. Among them, the compounds having a 1,5-dihydroxy-4-pyridone-2-carbonyl group showed excellent anti-pseudomonal activity. In particular, (6R,7R)-7-[(RS)-2-(2-aminothiazol-4-yl)-2-(1,5-dihydroxy-4- pyridone-2-carboxamido)- acetamido]-3-[[1-(2-hydroxyethyl)pyridinium-4-yl]thiomethyl]ceph-3 -em- 4-carboxylate (MT0703, 7g) was found to be a well balanced compound with respect to antibacterial activity.
制备了一系列在C-7取代基的α-氨基处带有单羟基或二羟基吡啶酮羰基的新型氨噻唑基甘氨酰头孢菌素,并研究了这些化合物的抗菌活性。其中,具有1,5-二羟基-4-吡啶酮-2-羰基的化合物表现出优异的抗假单胞菌活性。特别地,发现(6R,7R)-7-[(RS)-2-(2-氨基噻唑-4-基)-2-(1,5-二羟基-4-吡啶酮-2-甲酰胺基)-乙酰胺基]-3-[[1-(2-羟乙基)吡啶鎓-4-基]硫甲基]头孢-3-烯-4-羧酸酯(MT0703, 7g)在抗菌活性方面是一种平衡良好的化合物。